Publications

The epidemiologic impact and cost-effectiveness of new tuberculosis vaccines on multidrug-resistant tuberculosis in India and China.

WEERASURIYA, CK; Harris, RC; MCQUAID, CF; BOZZANI, F; Ruan, Y; Li, R; Li, T; Rade, K; Rao, R; Ginsberg, AM; Gomez, GB; WHITE, RG;

2021

BMC Medicine, (2021).19 1 10.1186/s12916-021-01932-7.

An approach for improving the quality of country-level TB modelling.

MCQUAID, CF; Clarkson, MC; Bellerose, M; Floyd, K; WHITE, RG; Menzies, NA;

2021

The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease, (2021).25 8 10.5588/ijtld.21.0127.

Antimicrobial resistance and COVID-19: Intersections and implications.

KNIGHT, GM; GLOVER, RE; MCQUAID, CF; OLARU, ID; GALLANDAT, K; LECLERC, QJ; FULLER, NM; WILLCOCKS, SJ; Hasan, R; Van Kleef, E; CHANDLER, CI;

2021

eLife, (2021).10, 10.7554/eLife.64139.

Tuberculosis in the Western Pacific Region: Estimating the burden of disease and return on investment 2020–2030 in four countries.

Estill, J; Islam, T; HOUBEN, RM G J; Rudman, J; Ragonnet, R; McBryde, ES; Trauer, JM; Orel, E; Nguyen, AT; Rahevar, K; Morishita, F; Oh, KH; Raviglione, MC; Keiser, O;

2021

The Lancet Regional Health - Western Pacific, (2021).11, 10.1016/j.lanwpc.2021.100147.

The impact of COVID-19 on global tuberculosis control.

Lipman, M; MCQUAID, CF; Abubakar, I; KHAN, M; KRANZER, K; McHugh, TD; Padmapriyadarsini, C; Rangaka, MX; Stoker, N;

2021

The Indian journal of medical research, (2021).153 4 10.4103/ijmr.IJMR_326_21.

Strengthening health systems to improve the value of tuberculosis diagnostics in South Africa: A cost and cost-effectiveness analysis.

FOSTER, N; Cunnama, L; McCarthy, K; Ramma, L; Siapka, M; Sinanovic, E; Churchyard, G; FIELDING, K; GRANT, AD; Cleary, S;

2021

PLOS ONE, (2021).16 5 10.1371/journal.pone.0251547.

Diagnostic Accuracy of the Cepheid 3-gene Host Response Fingerstick Blood Test in a Prospective, Multi-site Study: Interim Results.

SUTHERLAND, JS; Van der Spuy, G; Gindeh, A; Thuong, NT T; Namuganga, A; Owolabi, O; Mayanja-Kizza, H; Nsereko, M; Thwaites, G; Winter, J; DOCKRELL, HM; Scriba, TJ; Geluk, A; Corstjens, P; Stanley, K; Richardson, T; Shaw, JA; Smith, B; Malherbe, ST; Walzl, G; TrENDx-TB Consortium,;

2021

Clinical infectious diseases, (2021).74 12 10.1093/cid/ciab839.

Does Ghana's National Health Insurance Scheme provide financial protection to tuberculosis patients and their households?.

PEDRAZZOLI, D; CARTER, DJ; BORGHI, J; Laokri, S; BOCCIA, D; HOUBEN, RM;

2021

Social Science and Medicine, (2021).277, 10.1016/j.socscimed.2021.113875.

Digital adherence technology for TB: focus on livelihoods as well as lives.

MCQUAID, CF; FOSTER, N; QUAIFE, M; Levy, J; TADESSE, AW; Charalambous, S; Alacapa, JV; Deyanova, N; Mganga, A; HOUBEN, RM G J; FIELDING, KL;

2021

International journal of tuberculosis and lung disease, (2021).25 5 10.5588/ijtld.21.0070.

Neutrophils Contribute to Severity of Tuberculosis Pathology and Recovery From Lung Damage Pre- and Posttreatment.

Nwongbouwoh Muefong, C; Owolabi, O; Donkor, S; Charalambous, S; Bakuli, A; Rachow, A; Geldmacher, C; SUTHERLAND, JS;

2021

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, (2021).74 10 10.1093/cid/ciab729.